Bloomberg News

Stada Units Received Contracts for 76 Active Ingredients

October 31, 2011

Oct. 31 (Bloomberg) -- Stada Arzneimittel AG’s sales companies STADApharm GmbH, ALIUD PHARMA GmbH and cell pharm Gesellschaft fuer pharmazeutische und diagnostische Praeparate mbH received contracts for 76 active ingredients from a total of 200 in the last round of tenders with German public health insurers KKH-Allianz, Vereinigten IKK and Techniker Krankenkasse. The tender rounds were for discount argreements.

Link to Statement:{NSN LTXK893PR6RK <GO>}

To contact the editor responsible for this story: Mariajose Vera at mvera1@bloomberg.net


Soul Searcher
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus